country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-158197

Copy Link Print Information

RC-106

RC-106 is a proteasome inhibitor (IC50: 35 μM) and Sigma receptor modulator with anticancer activity. RC-106 has antiproliferative activity against cancer cells including glioblastoma (GB) and multiple myeloma (MM).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 1346216-50-9
Formel: C₂₆H₂₉N
Molecular Weight:355.52

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (265 KB)

RC-106 Chemical Structure

CAS. Nr.: 1346216-50-9

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Alle Sigma Receptor Isoform-spezifische Produkte anzeigen :

Cellular Effect

Cell Line	Type	Value	Description	References
Capan-2	IC₅₀	52.6 μM Compound: 3	Cytotoxicity against human Capan2 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay Cytotoxicity against human Capan2 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay	[PMID: 27614411]
Capan-2	IC₅₀	9.61 μM Compound: 3	Cytotoxicity against human Capan2 cells assessed as reduction in cell viability after 24 hrs in absence of 10% fetal calf serum by MTS assay Cytotoxicity against human Capan2 cells assessed as reduction in cell viability after 24 hrs in absence of 10% fetal calf serum by MTS assay	[PMID: 27614411]
LNCaP	IC₅₀	61.1 μM Compound: 3	Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay	[PMID: 27614411]
LNCaP	IC₅₀	9.58 μM Compound: 3	Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs in absence of 10% fetal calf serum by MTS assay Cytotoxicity against human LNCAP cells assessed as reduction in cell viability after 24 hrs in absence of 10% fetal calf serum by MTS assay	[PMID: 27614411]
MDA-MB-231	IC₅₀	64.9 μM Compound: 3	Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay	[PMID: 27614411]
PC-3	IC₅₀	50.6 μM Compound: 3	Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay Cytotoxicity against human PC3 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay	[PMID: 27614411]
SUM-159-PT	IC₅₀	58.3 μM Compound: 3	Cytotoxicity against human SUM159 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay Cytotoxicity against human SUM159 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay	[PMID: 27614411]
U-87MG ATCC	IC₅₀	10.47 μM Compound: 3	Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs in absence of 10% fetal calf serum by MTS assay Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs in absence of 10% fetal calf serum by MTS assay	[PMID: 27614411]
U-87MG ATCC	IC₅₀	60.6 μM Compound: 3	Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay Cytotoxicity against human U87 cells assessed as reduction in cell viability after 24 hrs in presence of 10% fetal calf serum by MTS assay	[PMID: 27614411]

In Vitro

RC-106 (60 μM; 24 h) inhibits cancer cell activity^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:

U87-MG cells
Concentration:

40, 60 μM
Incubation Time:

24 h
Result:

Showed a moderate activity against U87-MG cells at 60 μM, reducing the cell viability to 34%。

Chemical Information

CAS. Nr. 1346216-50-9
Molecular Weight 355.52
Formel C₂₆H₂₉N
SMILES

C/C(C1=CC2=C(C=CC=C2)C=C1)=C\CN3CCC(CC3)CC4=CC=CC=C4
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (265 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Listro R, et al. Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents. Front Chem. 2020 Jun 30;8:495. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen

Amount: USD 0.00

Biologische Aktivität
- Beschreibung
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

RC-106

Alle Sigma Receptor Isoform-spezifische Produkte anzeigen

Biologische Aktivität

Chemical Information

Reinheit & Dokumentation

Verweise

Calculators

Help & FAQs

RC-106 Related Classifications

HY-158197 Related Classifications